Intersections between blood cell development and leukemia genes

Cancer Research

Volumn 59, Issue 7 SUPPL., 1999, Pages

  Orkin, Stuart H ^a,b   Porcher, Catherine ^a   Fujiwara, Yuko ^a   Visvader, Jane ^a   Wang, Li Chun ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HELIX LOOP HELIX PROTEIN; ONCOPROTEIN; TRANSCRIPTION FACTOR;

ANGIOGENESIS; ANIMAL CELL; CELL DIFFERENTIATION; CELL FATE; CELL INTERACTION; CELL MATURATION; CHROMOSOME TRANSLOCATION; CONFERENCE PAPER; GENE TARGETING; HEMATOPOIESIS; MOUSE; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; T CELL LEUKEMIA;

ANIMALS; BONE MARROW CELLS; CELL LINEAGE; GENE TARGETING; HELIX-LOOP-HELIX MOTIFS; HEMATOPOIESIS; HUMANS; LEUKEMIA; LEUKEMIA, T-CELL; NEOPLASM PROTEINS; NEOVASCULARIZATION, PATHOLOGIC; ONCOGENES; TRANSCRIPTION FACTORS;

EID: 0033119549     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (46)

1. Orkin, S. H. Development of the hematopoietic system. Curr. Opin. Genet. Dev., 6: 597-602, 1996.
2. Rabbitts, T. H. Chromosomal translocations in human cancer. Nature (Lond.), 372: 143-149, 1994.
3. Begley, C. G., Aplan, P. D., Denning, S. M., Haynes, B. F., Waldmann, T. A., and Kirsch, I. R. The gene SCL is expressed during early hematopoiesis and encodes a differentiation-related DNA-binding motif. Proc. Natl. Acad. Sci. USA, 86: 10128-10132, 1989.
4. Golub, T. R., Barker, G. F., Lovett, M., and Gilliland, D. G. Fusion of PDGF receptor β to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation. Cell, 77: 307-316, 1994.
5. Green, A. R., Lints, T., Visvader, J., Harvey, R., and Begley, C. G. SCL is coexpressed with GATA-1 in hemopoietic cells but is also expressed in developing brain. Oncogene, 6: 475-479, 1992.
6. Mouthon, M-A., Bernard, O., Mitjavila, M-T., Romeo, P-H., Vainchenker, W., and Mathieu-Mahul, D. Expression of tal-1 and GATA-binding proteins during human hematopoiesis. Blood, 81: 647-655, 1993.
7. Visvader, J., Begley, C. G., and Adams, J. M. Differential expression of the Lyl, SCL, and E2a helix-loop-helix genes within the hemopoietic system. Oncogene, 6: 187-194, 1991.
8. Olson, E. N., and Klein, W. H. bHLH factors in muscle development: dead lines and commitments, what to leave in and what to leave out. Genes Dev., 8: 1-8, 1994.
9. Kelliher, M. A., Seldin, D. C., and Leder, P. Tal-1 induces T cell acute lymphoblastic leukemia accelerated by casein kinase IIα. EMBO J., 115: 5160-5166, 1996.
10. Condorelli, G. L., Facchiano, F., Valtieri, M., Proietti, E., Vitelli, L., Lulli, V., Huebner, K., Peschle, C., and Croce, C. M. T-cell-directed TAL-1 expression induces T-cell malignancies in transgenic mice. Cancer Res., 56: 5113-5119, 1996.
11. Larson, R. C., Lavenir, I., Larson, T. A., Baer, R., Warren, A. J., Wadman, I., Nottage, K., and Rabbitts, T. H. Protein dimerization between Lmo2 (Rbtn2) and Tal1 alters thymocyte development and potentiates T cell tumorigenesis in transgenic mice. EMBO J., 15: 1021-1027, 1996.
12. Aplan, P. D., Nakahara, K., Orkin, S. H., and Kirsch, I. R. The SCL gene product: a positive regulator of erythroid differentiation. EMBO J., 11: 4073-4081, 1992.
13. Shivdasani, R., Mayer, E., and Orkin, S. H. Absence of blood formation in mice lacking the T-cell leukemia oncoprotein tal-1/SCL. Nature (Lond.), 373: 432-434, 1995.
14. Robb, L., Lyons, I., Li, R., Hartley, L., Kontgen, F., Harvey, R. P., Metcalf, D., and Begley, C. G. Absence of yolk sac hematopoiesis from mice with a targeted disruption of the scl gene. Proc. Natl. Acad. Sci. USA, 92: 7075-7079, 1995.
15. Porcher, C., Swat, W., Rockwell, K., Fujiwara, Y., Alt, F. W., and Orkin, S. H. The T-cell leukemia oncoprotein SCL/tal-1 is essential for development of all hematopoietic lineages. Cell, 86: 47-57, 1996.
16. Robb, L., Elwood, N. J., Elefanty, A. G., Kontgen, F., Li, R., Barnett, L. D., and Begley, C. G. The scl gene product is required for the generation of all hematopoietic lineages in the adult mouse. EMBO J., 15: 4123-4129, 1996.
17. Hwang, L-Y., Siegelman, M., Davis, L., Oppenheimer-Marks, N., and Baer, R. Expression of the TAL1 proto-oncogene in cultured endothelial cells and blood vessels of the spleen. Oncogene, 8: 3043-3046, 1993.
18. Kallianpur, A. R., Jordan, J. E., and Brandt, S. J. The SCL/TAL-1 gene is expressed in progenitors of both the hematopoietic and vascular systems dunng embryogenesis. Blood, 83: 1200-1208, 1994.
19. Pardanaud, L., Yassine, F., and Dieterlen-Lievre, F. Relationship between vasculogenesis, angiogenesis, and haemopoiesis during avian ontogeny. Development (Camb.), 105: 473-485, 1989.
20. Choi, K., Kennedy, M., Kazarov, A., Papadimitriou, J. C., and Keller, G. A common precursor for hematopoietic and endothelial cells. Development (Camb.), 125: 725-732, 1998.
21. Visvader, J. E., Fujiwara, Y., and Orkin, S. H. Unsuspected role for the T-cell leukemia protein SCL/tal-1 in vascular development. Genes Dev., 12: 473-479, 1998.
22. Liao, E. C., Paw, B. H., Oates, A. C., Pratt, S. J., Postlethwait, J. H., and Zon, L. I. SCL/Tal-1 transcription factor acts downstream of cloche to specify hematopoietic and vascular progenitors in zebrafish. Genes Dev., 12: 621-626, 1998.
23. Drake, C. J., Brandt, S. J., Trusk, T. C., and Little, C. D. TAL1/SCL is expressed in endothelial progenitor cells/angioblasts and defines a dorsal-to-ventral gradient of vasculogenesis. Dev. Biol., 192: 17-30, 1997.
24. Golub, T. R., Barker, G. F., Stegmaier, K., and Gilliland, D. G. The TEL gene contributes to the pathogenesis of myeloid and lymphoid leukemias by diverse molecular genetic mechanisms. Curr. Top. Microbiol. Immunol., 220: 67-79, 1997.
25. Golub, T. R., Barker, G. F., Bohlander, S. K., Hiebert, S., Ward, D. C., Bray-Ward, P., Morgan, E., Raimondi, S. C., Rowley, J. D., and Gilliland, D. G. Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia. Proc. Natl. Acad. Sci. USA, 92: 4917-4921, 1995.
26. Romana, S. P., Mauchauffe, M., Le Coniat, M., Chumakov, I., Le Paslier, D., Berger, R., and Bernard, O. A. The t(12;21) of acute lymphoblastic leukemia results in a tel-AML1 gene fusion. Blood. 85: 3662-3670, 1995.
27. Shurtleff, S. A., Buija, A., Behm, F. G., Rubnitz, J. E., Raimondi, S. C., Hancock, M. L., Chan, G. C., Pui, C. H., Grosveld, G., and Downing, J. R. TEL/AML1 fusion resulting from cryptic t(12;21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosis. Leukemia (Baltimore), 9: 1985-1989, 1995.
28. McLean, T. W., Ringold, S., Neuberg, D., Stegmaier, K., Tantravahi, R., Ritz, J., Koeffler, H. P., Takeuchi, S., Janssen, J. W. G., Seriu, T., Bartram, C. R., Sallan, S. E., Gilliland, D. G., and Golub, T. R. TEL/AML-1 dimerizes and is associated with a favorable outcome in childhood acute lymphoblastic leukemia. Blood, 88: 4252-4258, 1996.
29. Sato, Y., Suto, Y., Pietenpol, J., Golub, T. R., Gilliland, D. G., Davis, E. M., Le Beau, M. M., Roberts, J. M., Vogelstein, B., Rowley, J. D., and Bohlander, S. K. TEL and KIP1 define the smallest region of deletions on 12p13 in hematopoietic malignancies. Blood, 86: 1525-1533, 1995.
30. Stegmaier, K., Pendse, S., Barker, G. F., Bray-Ward, P., Ward, D. C., Montgomery, K. T., Krauter, K. S., Reynolds, C., Sklar, J., Donnelly, M., Bohlander, S. K., Rowley, J. D., Sallan, S. E., Gilliland, D. G., and Golub, T. R. Frequent loss of heterozygosity at the TEL gene locus in acute lymphoblastic leukemia of childhood. Blood, 86: 38-44, 1995.
31. Kim, D-H., Moldwin, R. L., Vignon, C., Bohlander, S. K., Suto, Y., Giordano, L., Gupta, R., Fears, S., Nucifora, G., Rowley, J. D., and Smith, S. D. TEL-AML1 translocations with TEL and CDKN2 inactivation in acute lymphoblastic leukemia cell lines. Blood, 88: 785-794, 1996.
32. Raynaud, S., Cave, H., Baens, M., Bastard, C., Cacheux, V., Grosgeorge, J., Guidal-Giroux, C., Guo, C., Vilmer, E., Marynen, P., and Grandchamp, B. The 12;21 translocation involving TEL and deletion of the other TEL allele: two frequently associated alterations found in childhood acute lymphoblastic leukemia. Blood, 87: 2891-2899, 1996.
33. Wang, L. C., Kuo, F., Fujiwara, Y., Gilliland, D. G., Golub, T. R., and Orkin, S. H. Yolk sac angiogenic defect and intra-embryonic apoptosis in mice lacking the Ets-related factor TEL. EMBO J., 16: 4374-4383, 1997.
34. Wang, L-C., Swat, W., Fujiwara, Y., Davidson, L., Visvader, J., Kuo, F., Alt, F. W., Gilliland, D. G., Golub, T. R., and Orkin, S. H. The translocation-ets-leukemia (TEL/ETV6) gene is required specifically for hematopoiesis in the bone marrow. Genes Dev., in press, 1998.
35. Verfaillie, C. M. Stem cells in chronic myelogenous leukemia. Hematol. Oncol. Clin. North Am., 11: 1079-1114, 1997.
36. Shivdasani, R. A., and Orkin, S. H. The transcriptional control of hematopoiesis. Blood, 87: 4025-4039, 1996.
37. Valge-Archer, V. E., Osada, H., Warren, A. J., Forster, A., Li, J., Baer, R., and Rabbitts, T. H. The LIM protein RBTN2 and the basic helix-loop-helix protein TAL1 are present in a complex in erythroid cells. Proc. Natl. Acad. Sci. USA, 91: 8617-8621, 1994.
38. Yamada, Y., Warren, A. J., Dobson, C., Forster, A., Pannell, R., and Rabbitts, T. H. The T cell leukemia LIM protein Lmo2 is necessary for adult mouse hematopoiesis. Proc. Natl. Acad. Sci. USA, 95: 3890-3895, 1998.
39. Osada, H., Grutz, G., Axelson, H., Forster, A., and Rabbitts, T. H. Association of erythroid transcription factors: complexes involving the LIM protein RBTN2 and the zinc-finger protein GATA1. Proc. Natl. Acad. Sci. USA, 92: 9585-9589, 1995.
40. Pevny, L., Simon, M. C., Robertson, E., Klein, W. H., Tsai, S-F., D'Agati, V., Orkin, S. H., and Costantini, F. Erythroid differentiation in chimeric mice blocked by a targeted mutation in the gene for transcription factor GATA-1. Nature (Lond.), 349: 257-260, 1991.
41. Fujiwara, Y., Browne, C. P., Cunniff, K., Goff, S. C., and Orkin, S. H. Arrested development of embryonic red cell precursors in mouse embryos lacking transcription factor GATA-1. Proc. Natl. Acad. Sci. USA, 93: 12355-122358, 1996.
42. Shivadasani, R. A., Fujiwara, Y., McDevitt, M. A., and Orkin, S. H. A lineage-selective knockout establishes the critical role of transcription factor GATA-1 in megakaryocyte growth and platelet development. EMBO J., 16: 3965-3973, 1997.
43. Wadman, I. S., Osada, H., Grutz, G. G., Agulnick, A. D., Westphal, H., Forster, A., and Rabbitts, T. H. The LIM-only protein Lmo2 is a bridging molecule assembling an erythroid, DNA-binding complex which include TAL1, E47, GATA-1, and Ldb1/ NL1 proteins. EMBO J., 16: 3145-3157, 1997.
44. Tsai, F-Y., Keller, G., Kuo, F. C., Weiss, M. J., Chen, J-Z., Rosenblatt, M., Alt, F., and Orkin, S. H. An early haematopoietic defect in mice lacking the transcription factor GATA-2. Nature (Lond.), 371: 221-226, 1994.
45. Ting, C-N., Olson, M. C., Barton, K. P., and Leiden, J. M. Transcription factor GATA-3 is required for development of the T-cell lineage. Nature (Lond.), 384: 474-478, 1996.
46. Orkin, S. H. Transcription factors regulating early hematopoietic development and lineage commitment. In: J. G. Monroe and E. V. Rothenberg (eds.), Molecular Biology of B-cell and T-cell Development. Totowa, NJ: Humana Press, Inc., 1998.